PROCTER & GAMBLE HEALTH
|
The Current P/E Ratio of PROCTER & GAMBLE HEALTH is 30.21.
| Share Price | ₹5,341.7 | May 20,2026 |
| Market Cap | ₹8,867.1 Cr | |
| Earnings-TTM | ₹293.5 Cr | TTM-Standalone Results |
| Price/Earnings | 30.21x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of PROCTER & GAMBLE HEALTH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹8,867.1 Cr] as on May 20,2026
(/) Earnings [ ₹293.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 30.21x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay 30.21 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PROCTER & GAMBLE HEALTH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PE (Price/Earnings) ratio chart of PROCTER & GAMBLE HEALTH
PE Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Mar2025 to Jun2022 averaged 38.21x.
- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 37.97x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Jun2024 at 41.71x.
- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Jun2022 of 36.1x.
How does PROCTER & GAMBLE HEALTH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| PROCTER & GAMBLE HEALTH | 293.49 | 30.21 | 8,867.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 41.01 | 451,195.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 73.82 | 182,993.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 65.99 | 149,926.0 |
| CIPLA LTD | 3,869.79 | 29.21 | 113,052.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 26.62 | 110,333.0 |
| MANKIND PHARMA LTD | 1,926.41 | 55.37 | 106,669.0 |
| LUPIN LTD | 5,355.47 | 19.49 | 104,401.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 20.84 | 104,744.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 24.86 | 87,336.6 |
| LAURUS LABS LTD | 889.85 | 82.59 | 73,490.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PROCTER & GAMBLE HEALTH 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.49x |
| Max industry PE | 82.59x |
| Median industry PE | 30.21x |
| Average industry PE | 42.73x |
You may also like the below Video Courses